Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU) Reaches New 12-Month High – Time to Buy?

by · The Markets Daily

Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU – Get Free Report)’s stock price reached a new 52-week high on Monday . The company traded as high as $307.00 and last traded at $300.50, with a volume of 92730 shares changing hands. The stock had previously closed at $303.45.

Direxion Daily S&P Biotech Bull 3x Shares Stock Performance

The stock has a 50-day moving average price of $199.23 and a 200-day moving average price of $179.11.

Institutional Investors Weigh In On Direxion Daily S&P Biotech Bull 3x Shares

Hedge funds and other institutional investors have recently bought and sold shares of the business. Squarepoint Ops LLC raised its position in shares of Direxion Daily S&P Biotech Bull 3x Shares by 33.2% in the 2nd quarter. Squarepoint Ops LLC now owns 161,146 shares of the company’s stock valued at $9,171,000 after purchasing an additional 40,157 shares in the last quarter. Tower Research Capital LLC TRC increased its stake in shares of Direxion Daily S&P Biotech Bull 3x Shares by 664.7% in the third quarter. Tower Research Capital LLC TRC now owns 58,171 shares of the company’s stock worth $5,445,000 after buying an additional 50,564 shares during the last quarter. JPMorgan Chase & Co. bought a new stake in shares of Direxion Daily S&P Biotech Bull 3x Shares in the third quarter worth $3,208,000. Renaissance Technologies LLC raised its holdings in Direxion Daily S&P Biotech Bull 3x Shares by 10.6% in the fourth quarter. Renaissance Technologies LLC now owns 22,900 shares of the company’s stock valued at $3,650,000 after acquiring an additional 2,200 shares in the last quarter. Finally, Virtu Financial LLC bought a new position in Direxion Daily S&P Biotech Bull 3x Shares during the 3rd quarter valued at $1,757,000.

About Direxion Daily S&P Biotech Bull 3x Shares

(Get Free Report)

The Direxion Daily S&P Biotech Bull 3X Shares (LABU) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times exposure to the S&P Biotechnology Select Industry Index. LABU was launched on May 28, 2015 and is managed by Direxion.

See Also